LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES

USPTO USPTO 2006 IR CANCELLED; US REGISTRATION CANCELLED

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES was filed as Word and figurative mark on 03/07/2006 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 02/06/2007. The current status of the mark is "IR CANCELLED; US REGISTRATION CANCELLED".

Trademark Details

Trademark form Word and figurative mark
File reference 79025194
Register number 3206472
Application date March 7, 2006
Publication date November 21, 2006
Entry date February 6, 2007

Trademark owner

DK-2880 Bagsværd

Trademark representatives

goods and services

16 Printed newsletters, journals and magazines related to medical studies and research regarding pharmaceutical preparations for the treatment of diabetes-related diseases and disorders
42 Medical and scientific research, namely, conducting clinical trials and studies relating to pharmaceutical preparations for the treatment of diabetes-related diseases and disorders, and providing scientific information on the efficacy of pharmaceutical preparations for the treatment of diabetes-related diseases and disorders
44 Providing medical information on the efficacy of pharmaceutical preparations for the treatment of diabetes-related diseases and disorders

ID: 1379025194